BioCardia
BCDA
9 hedge funds and large institutions have $317K invested in BioCardia in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
39% more capital invested
Capital invested by funds: $228K → $317K (+$88.8K)
1.86% less ownership
Funds ownership: 4.76% → 2.9% (-1.9%)
10% less funds holding
Funds holding: 10 → 9 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$74.9K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.93K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$6 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
-$32K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5.05K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $220K | +$74.9K | +26,039 | +58% |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $46K | +$4.93K | +1,715 | +13% |
|
3
Vanguard Group
Malvern,
Pennsylvania
| $40.2K | – | – | – |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $4K | -$5.05K | -1,754 | -58% |
|
|
PP
5
Pingora Partners
Wilson,
Wyoming
| $3.23K | – | – | – |
|
|
6
Bank of America
Charlotte,
North Carolina
| $1.39K | +$6 | +2 | +0.5% |
|
|
GRP
7
Global Retirement Partners
San Rafael,
California
| $1.28K | – | – | – |
|
|
8
Osaic Holdings
Scottsdale,
Arizona
| $190 | -$32K | -11,128 | -99% |
|
9
Morgan Stanley
New York
| $94 | – | – | – |
|
BCDA Hedge Fund Activity: Q3 2024 in Review
9 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in BioCardia (BCDA) for Q3 2024, worth a combined $317K — up 39% from $228K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BCDA and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 3 added.
The largest buyer was Susquehanna International Group, adding an estimated $74.9K. The largest seller was Osaic Holdings, cutting an estimated $32K.
- 9 institutional investors held BioCardia (BCDA) as of Q3 2024, down from 10 in Q2 2024.
- Funds reported $317K of BioCardia stock for Q3 2024, up 39% quarter-over-quarter.
- 0 funds opened new BioCardia positions in Q3 2024 and 1 closed out, a net change of -1 holder.
- The largest BioCardia buyer in Q3 2024 was Susquehanna International Group, an estimated $74.9K added.
- The largest BioCardia seller in Q3 2024 was Osaic Holdings, an estimated $32K sold.
Based on aggregated 13F filings for Q3 2024.